Determination of survival associated genetic biomarkers to discover novel therapeutic targets for acute myeloid leukaemia
{{output}}
Acute myeloid leukemia (AML) is a heterogeneous malignancy specified by clonal proliferation of hematopoietic stem cells. This study identifies novel therapeutics for AML by integrating differential gene expression (DEG) and survival analyses. Publicly availab... ...
